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Abstract
Introduction Adrenal insufficiency is common in critically ill
patients and affects their prognosis, but little is known about
how adrenal function changes during prolonged critical illness.
This study was conducted to investigate dynamic changes in
cortisol levels in patients with critical illness who do not improve
after treatment.
Methods This observational cohort study was performed in the
intensive care units of a university hospital. We studied acutely
ill patients with initial cortisol level above 34 μg/dl, but who did
not improve after treatment and in whom follow-up cortisol levels
were determined during critical illness. All clinical information
and outcomes were recorded.
Results Fifty-seven patients were included. Ten patients had
follow-up cortisol levels above 34 μg/dl, 32 patients had levels
between 34 and 15 μg/dl, and 15 patients had levels under 15
μg/dl. Outcomes did not differ significantly among the three
groups with different follow-up cortisol levels. In Cox regression
analysis, those patients who survived to hospital discharge with
second cortisol levels under 15 μg/dl had a longer hospital
length of stay (odds ratio = 14.8, 95% confidence interval = 2.4
to 90.0; P = 0.004).
Conclusion The majority of acutely ill patients who remained in
a critical condition had decreased serum cortisol levels.
Depressed cortisol levels at follow up may lead to worse clinical
outcomes. We propose that repeated adrenal function testing
be conducted in patients with prolonged critical illness.
Introduction
Elevation in corticosteroid level to meet physiological needs
during acute illness is a protective response to stress. This
homeostasis is maintained by the hypothalamic-pituitary-adre-
nal (HPA) axis [1-6]. However, inadequate response as a
result of corticosteroid insufficiency is common in critically ill
patients, especially those with severe sepsis or septic shock
[7,8]. Thus, corticosteroids could be beneficial in the setting of
septic shock or severe acute illness [8-13].
The definition of corticosteroid insufficiency varies [3,7,8,14-
21]. The proposed values for diagnosis of corticosteroid insuf-
ficiency includes random cortisol levels below 15 μg/dl [3,14-
18], random cortisol levels under 10 μg/dl [19,20], random
cortisol level below 25 μg/dl [21], or corticotropin stimulation
test with an increase under 9 μg/dl [3,7,8,18,20]. Although
the corticotropin test is preferred in clinical practice, it would
be more useful to identify the level below which adrenal insuf-
ficiency is more likely and above which it is unlikely. Previous
studies have suggested that serum cortisol level below 15 μg/
dl should be regarded as adrenal insufficiency, warranting cor-
ticosteroid supplementation [3,14-16]. On the other hand,
adrenal insufficiency is not likely if the serum cortisol level is
above 34 μg/dl [3]. When the diagnosis of adrenal insuffi-
ciency is established in acute illness, extended treatment with
low-dose hydrocortisone may be required [8].
Once regarded as normal adrenal function, adrenal insuffi-
ciency may develop later with prolonged critical illness
[22,23]. It is easily overlooked and may occur as a result of
chronic secretion of systemic cytokines or of other substances
that suppress the HPA axis [24]. There is still no consensus on
how often adrenal function testing should be repeated,
although a re-evaluation should be considered if clinical symp-
toms and signs suggest adrenal insufficiency or deteriorating
clinical condition [22,23].
APACHE = Acute Physiology and Chronic Health Evaluation; HPA = hypothalamic-pituitary-adrenal; ICU = intensive care unit; IQR = interquartile 
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In this retrospective cohort study, we enrolled acutely ill
patients admitted to the intensive care units (ICUs) whose ini-
tial serum cortisol was above 34 μg/dl and who exhibited no
improvement within 2 weeks. The aim was to evaluate
changes in cortisol levels in these patients and to correlate
these changes with prognosis.
Materials and methods
Patients
All adult patients (age > 18 years) admitted to the ICUs of the
National Taiwan University Hospital between January 2005
and December 2006 were surveyed. The hospital is a tertiary
academic institution with a total of 141 beds in 14 ICUs. Each
of the 14 ICUs had a full-time ICU intensive care specialist and
at least three rotating residents. This study was approved by
the hospital's institutional review board.
Patients in whom cortisol levels were determined twice in the
ICU (follow-up cortisol level within 4 to 14 days after the first
cortisol determination) and in whom the initial cortisol level
was above 34 μg/dl were included. Patients were excluded if
there was clinical improvement (defined as a decrease in
Sequential Organ Failure Assessment [SOFA] between the
two cortisol level tests) and if they underwent steroid treat-
ment before the second cortisol level determination.
Data collection
The demographic data for the patients and the etiologies of
ICU admission were recorded. All of the clinical data between
two serum cortisol determinations were collected, including
body temperature, shock status, SOFA scores, Acute Physiol-
ogy and Chronic Health Evaluation (APACHE) II scores, dos-
ages of norepinephrine and dopamine, serum albumin levels,
and cortisol levels.
The ICU physician decided whether a patient should undergo
a serum cortisol test based on clinical features suggesting cor-
ticosteroid insufficiency, such as instable hemodynamic sta-
tus, fever with no obvious source, hypoglycemia, and so on.
Blood was drawn at 06:00 hours and cortisol assay was per-
formed on the same day. Serum cortisol levels were measured
using a commercially available solid-phase chemiluminescent
immunoassay (IMMULITE® 2000 Cortisol; Diagnostic Prod-
ucts, Los Angeles, CA, USA). Hydrocortisone 50 mg intrave-
nous every 6 hours was administered as a steroid supplement,
if clinically indicated. The usage duration and rate of tapering
depended on the ICU physician's judgment, based on the clin-
ical status of the patient.
Outcome evaluation
The primary outcome was mortality during the hospital admis-
sion. Secondary outcomes included duration of mechanical
ventilation and lengths of ICU and hospital stays. According to
the criteria proposed by Cooper and Steward [3], the patients
were stratified into three groups, based on the second (follow-
up) cortisol level: > 34 μg/dl, 34 to 15 μg/dl, and < 15 μg/dl.
Outcomes were compared among these three groups. Corti-
cotropin tests were not performed at the National Taiwan Uni-
versity Hospital because of the lack of available intravenously
injected corticotropin, and – under such circumstances – the
adrenal response to corticotropin was not used to stratify
patients.
Statistical analysis
All continuous variables were presented as medians (inter-
quartile range [IQR]), unless otherwise specified, and were
compared using nonparametric Mann-Whitney U-tests. All cat-
egorical variables were analyzed using the χ2 test, except
where small sample size mandated use of the Fisher's exact
test. The Kaplan-Meier method and log-rank test were used to
analyze time-related events between groups. We also con-
ducted multivariate Cox regression models to adjust for con-
founding factors. All of the statistical tests were two-tailed, and
differences at a P value < 0.05 were considered statistically
significant.
Results
In this cohort study, 12,908 sets of cortisol data from 6,926
patients were analyzed (Figure 1). From 109 patients who sat-
isfied the inclusion criteria, 52 exhibited clinical improvement
(decrease in SOFA score) and were excluded. Fifty-seven
patients remained for analysis. Their primary reasons for ICU
admission were pneumonia (40.4%), sepsis (26.3%), acute
myocardial infarction (8.8%), chronic obstructive pulmonary
disease (5.3%), congestive heart failure (5.3%), arrhythmia
(5.3%), hypovolemic shock (5.3%), and cerebrovascular acci-
dent (3.5%). The median age was 79 years, and 33 of the 57
patients were male.
The median initial cortisol level of the study population was
42.9 μg/dl, whereas the median second (follow-up) cortisol
level was 22.3 μg/dl (Table 1). The median (IQR) length of the
ICU stay was 28 days (27 days), and the median (IQR) hospi-
tal stay was 41 days (48 days). Thirty-two (56.1%) of the 57
patients died. Among the remaining 25 survivors who eventu-
ally discharged from hospital, seven were ventilator
dependent.
In the second cortisol level, 10 patients had cortisol levels
above 34 μg/dl (group 1), 32 patients had levels between 34
and 15 μg/dl (group 2), and 15 patients had levels below 15
μg/dl (group 3). The percentage of patients with a second cor-
tisol level below 34 μg/dl was high (47/57 [82.5%]), and adre-
nal insufficiency (cortisol level < 15 μg/dl) was identified in 15
out of 57 patients (26.3%; Table 1). No significant differences
in etiology and other demographic factors were identified
among the three groups, possibly because of the small
number of patients. There were also no significant differences
between the three groups in mortality, interval between the
two cortisol tests, or disease severity (SOFA and APACHE IIAvailable online http://ccforum.com/content/12/3/R65
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scores). Their serum albumin levels were also similar. Dura-
tions of mechanical ventilation, as well as length of ICU and
hospital stay increased with lower second cortisol level (group
3 > group 2 > group 1), although the increase did not reach
statistical significance. Ventilator dependence was more fre-
quent in adrenal insufficiency (group 3), but the difference was
not statistically significant.
In subgroup analysis (Table 2), patients who survived to hos-
pital discharge with adrenal insufficiency (group 3) had fewer
ventilator-free days and longer hospital stay than other
patients (groups 1 and 2), as estimated by univariate Kaplan-
Meier analysis (Figures 2a, b; log-rank P = 0.032 and 0.045,
respectively). We further conducted Cox regression models to
adjust for the following confounding factors: sex, age, reason
for ICU admission, and APACHE II score at ICU admission. A
second cortisol level below 15 μg/dl (group 3) was not asso-
ciated with a shorter ventilator-free duration in multivariate
models, but it was still related to shorter hospital stay (odds
ratio = 14.8, 95% confidence interval = 2.4 to 90.0; P =
0.004).
Eleven of 15 patients with definite adrenal insufficiency (group
3) underwent steroid supplementation (Table 3). The other
four patients (three survived and one died) did not use steroids
because of Mycobacteria tuberculosis infection and extreme
hypertension. Only two patients in group 2 received steroid,
based on the decision of attending physicians. We were una-
ble to identify any effect of steroid supplementation on survival,
possibly because of the small number of patients included.
Discussion
The definition of adrenal insufficiency in patients with critical ill-
ness remains controversial [3,20,21]. We used the definition
formulated by Copper and coworkers [3]: adrenal insufficiency
is likely if a random cortisol level is under 15 μg/dl and unlikely
if the cortisol level is above 34 μg/dl. We also defined adrenal
insufficiency based on work reported by Lipiner-Friedman and
colleagues [18], who found that patients with a cortisol level
below 15 μg/dl were more likely to die, to have a longer dura-
tion of shock, and to have a shorter survival time.
Although the physiological dose of corticosteroid used for
septic shock remains controversial, adrenal insufficiency con-
tinues to be an issue in critical care medicine [25-31]. Only a
few reports [22,23] have focused on the time course of corti-
sol levels in patients with prolonged illness. In the present
study we retrospectively analyzed cortisol levels in ICU
patients who did not improve after treatment, and we showed
that the majority of ICU patients who did not improve clinically
had decreasing serum cortisol levels during follow up.
All of the patients included in the study were still critically ill at
the time of the second blood draw for cortisol levels, all had
relatively high APACHE II score (median = 21 [IQR = 9]) and
SOFA score (median = 10 [IQR = 5]), and were frequently
hypotensive because of inotrope use. Based on the sugges-
tion of Cooper and Steward [3], 32 of the 57 (56.1%) patients
underwent further evaluation for adrenal insufficiency (cortisol
levels between 34 and 15 μg/dl) and 15 (26.3%) had adrenal
insufficiency (cortisol levels < 15 μg/dl). Corticosteroid sup-
plementation was warranted in these 15 patients.
Figure 1
Flow chart of patient recruitment Flow chart of patient recruitment. ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.Critical Care    Vol 12 No 3    Wu et al.
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Decreased cortisol levels during follow up is not unusual in
critically ill patients [22,23]. Guzman and coworkers [22] iden-
tified a group of patients who had septic shock with prolonged
use of inotropic agents. Repeated cortisol testing, with a mean
of 6 days after initial testing, revealed decreasing serum corti-
sol levels in most patients. In another study, Marik and col-
leagues [23] found that 16% of ICU patients with liver failure
developed adrenal insufficiency after initially normal cortisol
levels, which they described as adrenal exhaustion. In our
study, the patients received repeated cortisol testing at 4-day
to 14-day (median = 8 days [IQR = 5 days]) intervals. In ICU
patients who did not improve after this time interval, the physi-
Table 1
Patient characteristics
Variables All (n = 57) Group 1 (n = 10) Group 2 (n = 32) Group 3 (n = 15) P
Age (years) 79 (16) 75 (20) 80 (12) 71 (25) NS
Sex (n; male/female) 33/24 7/3 16/16 10/5 NS
First cortisol level (μg/dl) 42.9 (14.8) 49.3 (27.7) 41.4 (17.3) 42.0 (20.9) NS
Second cortisol level (μg/dl) 22.3 (15.8) 45.1 (25.5) 23.4 (9.3) 9.6 (8.8) < 0.05
Change in cortisol level (μg/dl) 24.7 (28.7) 0.8 (13.3) 21.1 (16.9) 34.8 (16.7) < 0.05
Time interval between both cortisol tests (days) 8 (5) 8 (3) 8 (6) 9 (5) NS
Etiologies (n)
Pneumonia 23 5 11 7 NS
Chronic obstructive pulmonary disease with acute 
exacerbation
3 012N S
S e p s i s 1 5 285N S
H y p o v o l e m i c  s h o c k 3 030N S
Cerebrovascular accident 2 0 1 1 NS
Congestive heart failure 3 0 3 0 NS
A r r h y t h m i a 3 120N S
Acute myocardial infarction 5 2 3 0 NS
Diabetes mellitus (n)1 7 4 1 2 1 N S
Malignancy (n)1 2 1 1 0 1 N S
First albumin level (g/dL) 3.0 (0.7) 3.0 (0.6) 2.9 (1.0) 3.0 (0.7) NS
Second albumin level (g/dL) 2.8 (0.8) 2.6 (0.5) 2.9 (1.1) 2.8 (0.6) NS
First SOFA score 9 (5) 10 (8) 9 (6) 8 (3) NS
Second SOFA score 10 (5) 13 (9) 10 (6) 9 (3) NS
First APACHE II score 21 (8) 22 (11) 21 (8) 19 (9) NS
Second APACHE II score 21 (9) 22 (10) 21 (7) 18 (10) NS
Change in body temperature (°C) 0.0 (1.1) 0.2 (3.1) 0.0 (0.8) 0.0 (1.0) NS
First dopamine dosage (μg/kg/min) 6.0 (11.0) 6.0 (20.0) 5.0 (4.8) 6.0 (13.0) NS
Second dopamine dosage (μg/kg/min) 4.0 (8.0) 5.0 (10.0) 3.5 (6.8) 4.0 (9.0) NS
First norepinephrine dosage (μg/min) 2.0 (1.0) 4.0 (4.0) 2.0 (1.0) 2.0 (1.0) NS
Second norepinephrine dosage (μg/min) 3.0 (4.5) 3.5 (8.5) 2.0 (1.0) 4.0 (6.0) NS
Mortality (n [%]) 32 (56%) 6 (60%) 17 (53%) 9 (60%) NS
Ventilator dependent (n [%]) 7 (12%) 1 (10%) 3 (9%) 3 (20%) NS
Mean ICU LOS (days) 28 (27) 23 (23) 26 (18) 41 (29) NS
Mean hospital LOS (day) 41 (48) 32 (22) 35 (36) 69 (26) NS
Unless otherwise stated, variables are presented as median (interquartile range). APACHE, Acute Physiology and Chronic Health Evaluation; 
LOS, length of stay; NS, nonsignificant; SOFA, Sequential Organ Failure Assessment.Available online http://ccforum.com/content/12/3/R65
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cians usually had to search for factors other than the original
diagnosis. Most of the patients with prolonged critical illness
included in our study exhibited a decrease in serum cortisol
levels over time. Some (26.3%) even became adrenally insuf-
ficient, based on the criteria used. Adrenal function might be a
dynamic process in patients with unstable hemodynamic sta-
tus after initial management. Whether the decline in cortisol
levels in patients with prolonged critical illness was an adapta-
tion or an exhaustion of the HPA axis remains to be investi-
gated [32].
In the study comparing patients with respiratory failure and dif-
ferent levels of adrenal function conducted by Huang and
coworkers [33], patients with adequate adrenal reserve under-
went successful weaning at a higher percentage than did
those with adrenal insufficiency. A similar finding was identi-
fied in our study. Our study was not sufficiently powered to
identify significant differences in overall mortality, duration of
mechanical ventilator use, and length of ICU and hospital stay
among the three groups, although we found a trend toward a
longer duration of mechanical ventilator use and ICU and
hospital stay in patients with lower second cortisol levels. Fur-
ther analysis revealed that, in terms of survival, patients with
adrenal insufficiency (group 3) had significantly longer ventila-
tor use and hospital stay. Because adaptation and mainte-
nance of homeostasis in the HPA axis is important in critical
illness, the decreased cortisol levels observed in patients with
prolonged critical illness included in our study might be due to
the exhaustion of adrenal function. However, further studies
with large patient numbers are necessary to address this issue
rigorously in prolonged critical illness.
Corticosteroid treatment in septic shock remains controver-
sial. Although treatments with low-dose hydrocortisone and
fludrocortisone were suggested by Annane and coworkers
[8], a recent study identified no benefit from 'physiologic
doses' of corticosteroids in septic shock [34]. However, the
durations of corticosteroid use in these two studies were only
7 days [8] and 11 days [34]. If the patients exhibited no
improvement after prolonged treatment in the ICUs, then start-
ing treatment with low-dose corticosteroid in these patients
might be another issue for further study.
Our study has several limitations. First, a corticotropin test was
not performed in our hospital. In this circumstance, group 2
patients (whose second serum cortisol level was between 34
μg/dl and 15 μg/dl) did not receive a corticotropin test.
Second, the study population was small. We speculate that if
larger numbers could be recruited, then differences in out-
comes among the three groups, such as survival rate, might be
significant. Third, the serum cortisol level measured in this
study was total cortisol, rather than the free form of cortisol.
However, there is no well documented evidence that free cor-
tisol has superior diagnostic efficacy to total cortisol level [34].
Fourth, the decision regarding whether to test the serum cor-
tisol level depended on the ICU physicians, and so there may
be a selection bias in the study population. This was a pilot
study in which we aimed to analyze adrenal function in patients
with prolonged critical illness. Large trials are necessary to
relate the outcomes of prolonged critical illness to relative
adrenal insufficiency. High-quality randomized control trials
are necessary to evaluate the efficacy of corticosteroids at
'physiologic doses' in these patients.
Figure 2
Mechanical ventilation and hospital length of stay Mechanical ventilation and hospital length of stay. Shown is a compari-
son of (a) duration of mechanical ventilation and (b) hospital length of 
stay. Patients who survived to hospital discharge with adrenal insuffi-
ciency (group 3 [second cortisol level < 15 μg/dl]) had longer ventilator 
duration and hospital stays than did others without adrenal insufficiency 
(groups 1 and 2 [second cortisol level ≥15 μg/dl]), as estimated by uni-
variate Kaplan-Meier analysis.Critical Care    Vol 12 No 3    Wu et al.
Page 6 of 7
(page number not for citation purposes)
Conclusion
Many ICU patients have decreased cortisol levels after pro-
longed treatment without clinical improvement. Whether there
is an adaptation or exhaustion of adrenal function is still to be
established. We propose that serum cortisol level testing be
repeated in patients with prolonged critical illness, even in
those whose initial adrenal function is within normal limits.
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Table 2
Outcome comparison of patients that survived to hospital discharge
Cortisol < 15 μg/dl (n = 6) Cortisol ≥15 μg/dl (n = 19) Kaplan-Meier (P) Cox regressiona (P)
Duration of mechanical ventilation (days) 66 (119) 16 (24) 0.032 0.055
ICU LOS (days) 37 (27) 20 (26) 0.157 0.160
Hospital LOS (days) 71 (88) 41 (41) 0.045 0.004
Values are presented as median (interquartile range). aAdjusted for age, sex, etiology of ICU admission, and APACHE II score at ICU admission. 
ICU, intensive care unit; LOS, length of stay.
Table 3
Clinical features of group 3 (second serum cortisol level < 15 μg/dl)
Patient Age/sex First cortisol (μg/dl) Second cortisol 
(μg/dl)
Outcome Ventilator 
dependent
Steroid use after 
second cortisol
Reason why steroid 
treatment witheld
1 83/male 40.9 14.4 Survived No No Active tuberculosis
2 58/male 95.6 14.4 Survived No Yes
3 76/female 58.5 14.4 Survived No No Extreme 
hypertension
4 79/male 34.0 12.7 Died No Yes
5 70/male 40.1 11.2 Died No No Active tuberculosis
6 88/female 38.6 10.6 Survived Yes No Active tuberculosis
7 87/male 38.1 10.2 Died No Yes
8 66/male 42.9 9.6 Died No Yes
9 71/male 67.0 9.5 Survived Yes Yes
10 82/female 42.0 5.6 Died No Yes
11 61/male 39.2 5.3 Died No Yes
12 53/female 45.3 3.9 Survived No Yes
13 83/male 37.4 3.6 Died No Yes
14 50/female 62.5 3.4 Died No Yes
15 45/male 37.6 2.8 Survived No Yes
Key messages
￿  Change in adrenal function is a dynamic process in ICU 
patients, but no guidelines are available to suggest how 
frequently serum cortisol level testing should be 
repeated.
￿  The present study suggests that the majority of long-
stay ICU patients who did not improve clinically had 
decreased cortisol levels.
￿  The decrease in cortisol levels may lead to poorer prog-
nosis, and more studies are required to clarify their 
importance.
￿  More data are required to draw a conclusion regarding 
whether steroid supplements are beneficial in ICU 
patients with prolonged critical illness.Available online http://ccforum.com/content/12/3/R65
Page 7 of 7
(page number not for citation purposes)
revised the manuscript. All authors read and approved the final
version of the manuscript.
References
1. Chrousos GP: Regulation and dysregulation of the hypotha-
lamic-pituitary-adrenal axis. The corticotropin-releasing hor-
mone perspective.  Endocrinol Metab Clin North Am 1992,
21:833-858.
2. Chrousos GP: The hypothalamic-pituitary-adrenal axis and
immune-mediated inflammation.  N Engl J Med 1995,
332:1351-1362.
3. Cooper MS, Steward PM: Corticosteroid insufficiency in acutely
ill patient.  N Engl J Med 2003, 348:727-734.
4. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Win-
terer JC, Loriaux DL: Daily cortisol production rate in an deter-
mined by stable isotope dilution/mass spectrometry.  J Clin
Endocrinol Metab 1991, 72:39-45.
5. Chernow B, Alexander HR, Smallridge RC, Thompson WR, Cook
D, Beardsley D, Fink MP, Lake CR, Fletcher JR: Hormonal
responses to graded surgical stress.  Arch Intern Med 1987,
147:1273-1278.
6. Barton RN, Stoner HB, Watson SM: Relationship among plasma
cortisol, adrenocorticotrophin, and severity of injury in recently
injured patients.  J Trauma 1987, 27:384-92.
7. Rothwell PM, Udwadia ZF, Lawler PG: Cortisol response to cor-
ticotropin and survival in septic shock.  Lancet 1991,
337:582-583.
8. Annane D, Sébille V, Charpentier C, Bollaert PE, François B,
Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-
Riffaut P, Bellissant E: Effect of treatment with low doses of
hydrocortisone and fludrocortisone on mortality in patients
with septic shock.  JAMA 2002, 288:862-871.
9. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ,
Stewart SM, Kennard BD, Olsen KD, McCracken GH Jr: Dexam-
ethasone therapy for bacterial meningitis: results of two dou-
ble-blind, placebo-controlled trials.  N Engl J Med 1988,
319:964-971.
10. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA,
Kelso T, Tolley EA: Effect of prolonged methylprednisolone
therapy in unresolving acute respiratory distress syndrome: a
randomized control trial.  JAMA 1998, 280:159-165.
11. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Lar-
can A: Reversal of late septic shock with supraphysiologic
doses of hydrocortisone.  Crit Care Med 1998, 26:645-650.
12. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hem-
mer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K: Stress
doses of hydrocortisone reverse hyperdynamic septic shock:
a prospective, randomized, double-blind, single-center study.
Crit Care Med 1999, 27:723-732.
13. de Gans J, Beek D van de: Dexamethasone in adults with bac-
terial meningitis.  N Engl J Med 2002, 347:1549-1556.
14. Jacobs HS, Nabarro JD: Plasma 11-hydroxycorticosteroid and
growth hormone levels in acute medical illnesses.  BMJ 1969,
2:595-598.
15. Kidess AI, Caplan RH, Reynertson RH, Wickus GG, Goodnough
DE: Transient corticotrophin deficiency in critical illness.  Mayo
Clin Proc 1993, 68:435-441.
16. Bouachour G, Tirot P, Varache N, Govello JP, Harry P, Alquier P:
Hemodynamic changes in acute adrenal insufficiency.  Inten-
sive Care Med 1994, 20:138-141.
17. Barquist E, Kirton O: Adrenal insufficiency in the surgical inten-
sive care unit patient.  J Trauma 1997, 42:27-31.
18. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman
SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, Bellissant
E, Annane D, CORTICUS Study Group: Adrenal function in sep-
sis: the retrospective Corticus cohort study.  Crit Care Med
2007, 35:1012-1008.
19. Knowlton AI: Adrenal insufficiency in the intensive care setting.
J Intensive Care Med 1989, 4:35-45.
20. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P:
Diagnosis of adrenal insufficiency in severe sepsis and septic
shock.  Am J Respir Crit Care Med 2006, 174:1319-1326.
21. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock.
Crit Care Med 2003, 31:141-145.
22. Guzman JA, Guzman CB: Adrenal exhaustion in septic patients
with vasopressor dependency.  J Crit Care 2007, 22:319-323.
23. Marik PE: Adrenal-exhaustion syndrome in patients with liver
disease.  Intensive Care Me 2006, 32:275-280.
24. Burchard K: A review of the adrenal cortex and severe inflam-
mation: quest of the 'eucorticoid' state.  J Trauma 2001,
51:800-814.
25. Hiebert JM, Egdhal RH: Cortisol responses to normotensive
and hypotensive oligemia in unanesthetized primates.  Surg
Forum 1972, 23:69-77.
26. Munck A, Guyre PM, Holbrook NJ: Physiological functions of
glucocorticoids in stress and their relation to pharmacological
actions.  Endocr Rev 1984, 5:25-44.
27. Sibbald WJ, Short A, Cohen MP, Wilson RF: Variations in adren-
ocortical responsiveness during severe bacterial infections:
unrecognized adrenocortical insufficiency in severe bacterial
infections.  Ann Surg 1977, 186:29-33.
28. Hume DM, Bell CC, Bartter F: Direct measurement of adrenal
secretion during operative trauma and convalescence.  Sur-
gery 1962, 52:174-187.
29. Cooper CE, Nelson DH: ACTH levels in plasma in preoperative
and surgically stressed patients.  J Clin Invest 1962,
41:1599-1605.
30. McIntosh TK, Lothrop DA, Lee A, Jackson BT, Nabseth D, Egdahl
RH:  Circadian rhythm of cortisol is altered in postsurgical
patients.  J Clin Endocrinol Metab 1981, 53:117-122.
31. Naito Y, Fukata J, Tamai S, Seo N, Nakai Y, Mori K, Imura H: Bipha-
sic changes in hypothalamopituitary-adrenal function during
the early recovery period after major abdominal surgery.  J Clin
Endocrinol Metab 1991, 73:111-117.
32. Beishuizen A, Thijs LG: The immunoneuroendocrine axis in crit-
ical illness: beneficial adaptation or neuroendocrine
exhaustion?  Curr Opin Crit Care 2004, 10:461-467.
33. Huang CJ, Lin HC: Association between adrenal insufficiency
and ventilator weaning.  Am J Respir Crit Care Med 2006,
173:276-280.
34. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K,
Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart
K, Cuthbertson BH, Payen D, Briegel J, CORTICUS Study Group:
Hydrocortisone therapy for patients with septic shock.  N Engl
J Med 2008, 358:111-124.